OBX insider filings
Obsidian Therapeutics, Inc. — 11 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-13. Screen OBX transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 5 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Feder Julie B — Chief Financial Officer | 1 | — | — | 1 |
| Hari Parameswaran — Chief Medical Officer | 1 | — | — | 1 |
| Jagasia Madan — Chief Executive Officer, Director | 1 | — | — | 1 |
| Reisenauer Mark L — Director | 2 | — | — | 1 |
Recent insider filings — Obsidian Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 3 | Reisenauer Mark L — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-13 | 4 | Hari Parameswaran — Chief Medical Officer | Grant/award (A): 331,173 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | Feder Julie B — Chief Financial Officer | Grant/award (A): 164,790 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | Reisenauer Mark L — Director | Grant/award (A): 75,364 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4/A | Jagasia Madan — Chief Executive Officer, Director | Grant/award (A): 678,477 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Barrett Peter — Director | Grant/award (A): 37,653 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Jagasia Madan — Chief Executive Officer, Director | Grant/award (A): 37,653 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Norkunas Matthew — Director | Grant/award (A): 37,653 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | ROSS ROBERT W. — Director | Grant/award (A): 37,653 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Fardis Maria — Director | Grant/award (A): 37,653 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Hagen Heidi — Director | Grant/award (A): 37,653 (derivative) @ $0 | EDGAR |
Recent 8-K events — Obsidian Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 4.01 — Changes in Registrant's Certifying Accountant 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — Obsidian Therapeutics, Inc.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-298642 (S-1) — latest: Initial registration (S-1), filed 2026-08-28
GET https://api.filingpulse.io/v1/insider-trades?ticker=OBX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs